Pancreatitis Trial, Recruiting NCT03099850 Sponsor: M.D. Anderson Cancer Center Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT03099850
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with chronic pancreatitis.

Who may not be able to join:

  • People who have a history of autoimmune pancreatitis, pancreatitis caused by injury, or a severe episode of acute necrotizing (tissue-destroying) pancreatitis that led to suspected complications (confirm with trial site).
  • People who have a primary pancreatic cancer or tumor, including certain cyst-forming tumors larger than 1 cm or involving the main pancreatic duct, hormone-producing tumors, or other rare pancreatic tumors.
  • People who have cancer that has spread to the pancreas from another part of the body.
  • People who have had a solid organ transplant (such as a kidney, liver, or heart transplant), or who have HIV/AIDS.
  • People whose pancreas does not produce enough digestive enzymes, where this condition exists on its own without meeting any of the other criteria for joining the trial.
  • People with a medical or psychiatric illness, or ongoing substance use, that the trial investigator believes would make it difficult to complete the study or attend follow-up visits.
  • People with significantly reduced kidney function (a GFR below 30) or kidney failure — this applies to certain subgroups within the trial (confirm with trial site which subgroup applies).
  • People who are not willing to attend follow-up visits over time.
  • People who are currently pregnant. People who could become pregnant must have a negative pregnancy test within 2 days before any research-related endoscopy or imaging procedure, unless surgical sterilisation has been confirmed or there has been no menstrual period for 2 or more years.
  • People who are currently in prison or a correctional facility.
  • People in certain subgroups of the trial who are unable to have an MRI scan — for example, due to having a metal object in the body that makes MRI unsafe (confirm with trial site which subgroups this applies to).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Li Liang, PHD, M.D. Anderson Cancer Center

Phone: 713-563-4276

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 February 2017
Est. completion
30 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Safety and adverse events (AEs). Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov